Ron Gladue

Accomplished pharmaceutical scientific and strategic leader with over 40 years of experience in drug discovery and development for immunological diseases (immune-oncology, autoimmunity, allergy, antibody-based therapies for infectious disease). He has held positions of increasing responsibility at Pfizer from 1980-2015 including Director and Head of Immunology Research as well as starting a new group focused on B cell repertoire screening to identify new antibody-based therapies for infectious disease.

He currently serves as a consultant for several pharmaceutical companies, serves on the Scientific Advisory Board for End Allergies Together Foundation for food allergy research, and is a Senior Scientific Strategist for the Jeffrey Modell Foundation for Primary Immunodeficiency Diseases. He has led over 14 drug discovery programs (small molecule and biologics), is a co-inventor on over 13 patents, published over 43 manuscripts, book chapters and reviews and gave over 54 presentations at national and international meetings.